{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-016054","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2023-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.587763+00:00","generated_at":"2026-06-16T05:13:18.446838+00:00","sec_items":["1.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tivic Health appoints interim CFO Kimberly Bambach, strategic advisor Christina Valauri; CFO Veronica Cai resigns","bullets":["CFO Veronica Cai resigned effective April 28, 2023; receives $125K lump sum upon signing release.","Kimberly Bambach appointed interim CFO, paid $200/hour as non-employee consultant.","Christina Valauri engaged as strategic advisor to board; former healthcare analyst at Cantor Fitzgerald.","Cai stated resignation not due to any disagreement with company's operations or policies.","Bambach brings 30+ years financial leadership; previously CFO of Jushi Holdings."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-016054","json":"https://secwatch.observer/filing/0000950170-23-016054.json","markdown":"https://secwatch.observer/filing/0000950170-23-016054.md","text":"https://secwatch.observer/filing/0000950170-23-016054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/tivc-20230428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T05:13:18.446838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6eed0715db","claim":"Kimberly Bambach was appointed as interim Chief Financial Officer and Principal Financial and Principal Accounting Officer at Valion Bio, Inc..","evidence_excerpt":"Effective April 28, 2023, Kimberly Bambach was appointed as the Company’s new interim Chief Financial Officer and Principal Financial and Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer and Principal Financial and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"b26e219065","claim":"Veronica Cai resigned as Chief Financial Officer at Valion Bio, Inc..","evidence_excerpt":"On April 28, 2023, Veronica Cai resigned from her role as Chief Financial Officer of Tivic Health Systems, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017023016054/0000950170-23-016054-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}